Basal and bolus insulin requirements in children, adolescents, and young adults with type 1 diabetes mellitus on continuous subcutaneous insulin infusion (CSII): effects of age and puberty
- PMID: 23757622
- DOI: 10.4158/EP13099.OR
Basal and bolus insulin requirements in children, adolescents, and young adults with type 1 diabetes mellitus on continuous subcutaneous insulin infusion (CSII): effects of age and puberty
Abstract
Objective: Guidelines for insulin dosing, including the insulin to carbohydrate ratio (I/C), insulin sensitivity factor (ISF), and basal/bolus ratio guidelines, have been well established for adults with type 1 diabetes mellitus (T1DM). However, clinical experience suggests that these guidelines are not appropriate for children. The purpose of this study was to determine the continuous subcutaneous insulin infusion (CSII) settings in children with T1DM at different ages and stages of puberty.
Methods: A total of 154 patients data between the ages of 3 and 21 years with well-controlled T1DM according to American Diabetes Association guidelines were reviewed. Only patients on CSII who were not in the honeymoon period were included.
Results: Patients were divided into 8 groups according to age, gender, and/or pubertal stage. Insulin requirements increased with puberty in both sexes (0.69, 0.97, and 0.90 U/kg/day in children <7 years of age, midpubertal girls, and late-pubertal boys, respectively). Basal insulin requirement was lowest in the youngest group (34%; P<.01). The youngest group had the lowest I/C prediction factor (PF) (mean, 315.7 ± 79.4; P<.01 with all groups), and the ISF-PF was higher than that of the oldest group (mean, 2,588.3 ± 1,101.8; P<.01).
Conclusion: CSII dose calculations vary with age and pubertal status in children with T1DM. These differences must be considered when calculating CSII dosing, especially for younger children.
Similar articles
-
Difference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment.Diabetes Technol Ther. 2009 Dec;11(12):767-74. doi: 10.1089/dia.2009.0049. Diabetes Technol Ther. 2009. PMID: 20001677
-
Age-related differences in metabolic response to continuous subcutaneous insulin infusion in pre-pubertal and pubertal children with Type 1 diabetes mellitus.J Endocrinol Invest. 2007 Jun;30(6):477-83. doi: 10.1007/BF03346331. J Endocrinol Invest. 2007. PMID: 17646722
-
Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.Diabetes Technol Ther. 2015 Dec;17(12):872-9. doi: 10.1089/dia.2015.0030. Epub 2015 Oct 28. Diabetes Technol Ther. 2015. PMID: 26509360
-
A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.Curr Diab Rep. 2016 Sep;16(9):83. doi: 10.1007/s11892-016-0772-0. Curr Diab Rep. 2016. PMID: 27457238 Free PMC article. Review.
-
Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.BMC Endocr Disord. 2022 Feb 19;22(1):43. doi: 10.1186/s12902-022-00950-7. BMC Endocr Disord. 2022. PMID: 35183150 Free PMC article.
Cited by
-
Determination of Pubertal Status in Youths With Type 1 Diabetes Using Height Velocity and Trajectories.J Clin Endocrinol Metab. 2019 Jan 1;104(1):74-82. doi: 10.1210/jc.2018-01737. J Clin Endocrinol Metab. 2019. PMID: 30346541 Free PMC article.
-
Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.Diabetes Technol Ther. 2020 Mar;22(3):174-184. doi: 10.1089/dia.2019.0286. Epub 2019 Oct 29. Diabetes Technol Ther. 2020. PMID: 31596130 Free PMC article. Clinical Trial.
-
Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience.Adv Med. 2018 Jun 5;2018:1473160. doi: 10.1155/2018/1473160. eCollection 2018. Adv Med. 2018. PMID: 29974056 Free PMC article.
-
Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.Diabetes Technol Ther. 2017 Jun;19(6):331-339. doi: 10.1089/dia.2016.0399. Epub 2017 May 1. Diabetes Technol Ther. 2017. PMID: 28459617 Free PMC article. Clinical Trial.
-
[Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association].Wien Klin Wochenschr. 2024 Jul;136(Suppl 9):467-477. doi: 10.1007/s00508-024-02400-x. Epub 2024 Aug 28. Wien Klin Wochenschr. 2024. PMID: 39196351 Free PMC article. German.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical